【レポートの概要（一部）】
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Disease Overview
06.1 Mode of Infection Transmission
06.2 Geographical Distribution
06.3 Screening
06.4 Treatment
06.4.1 WHO Guidelines
06.4.2 AASLD guidelines
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Key Marketed Drugs for Treatment of Chronic Hepatitis C
09. Market Segmentation by MOA
09.1 Virus-specific Agents
09.1.1 Polymerase Inhibitors
09.1.2 Protease Inhibitors
09.2 Non-specific Agents
09.2.1 IFN-based Drugs
09.2.2 Others
10. Geographical Segmentation
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.1.1 Key News
18.1.2 Mergers and Acquisitions
18.2 Market Share Analysis 2013
18.2.1 Roche
18.2.2 Merck
18.2.3 Johnson and Johnson
18.2.4 Vertex Pharmaceuticals
18.2.5 Gilead
18.3 Other Prominent Vendors
19. Key Vendor Analysis
19.1 F. Hoffmann La Roche
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2013
19.1.4 Business Segmentation by Revenue 2012 and 2013
19.1.5 Geographical Segmentation by Revenue 2013
19.1.6 Business Strategy
19.1.7 Recent Developments
19.1.8 SWOT Analysis
19.2 Gilead
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Geographical Segmentation by Revenue 2013
19.2.4 Recent Developments
19.2.5 SWOT Analysis
19.3 Johnson & Johnson
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 Business Segmentation by Revenue 2013
19.3.4 Business Segmentation by Revenue 2012 and 2013
19.3.5 Geographical Segmentation by Revenue 2013
19.3.6 Business Strategy
19.3.7 Recent Developments
19.3.8 SWOT Analysis
19.4 Merck
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Business Segmentation by Revenue 2013
19.4.4 Business Segmentation by Revenue 2012 and 2013
19.4.5 Sales by Geography
19.4.6 Business Strategy
19.4.7 Key Developments
19.4.8 SWOT Analysis
19.5 Vertex Pharmaceuticals
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Business Segmentation by Revenue 2013
19.5.4 Business Segmentation by Revenue 2012 and 2013
19.5.5 Geographical Segmentation by Revenue 2013
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
20. Other Reports in this Series
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Progression of Hepatitis C
Exhibit 3: Risk Factors for Hepatitis C Transmission
Exhibit 4: Prevalence Rates of Hepatitis C Across Different Geographies
Exhibit 5: Prevalence of Hepatitis C Genotypes in Tropical Latin America
Exhibit 6: Key Prevalence Data of Hepatitis C in East Asia and Pacific
Exhibit 7: Prevalence of Hepatitis C Genotypes in East Asia
Exhibit 8: Prevalence of Hepatitis C Genotypes in High Income Asia Pacific
Exhibit 9: Prevalence of Hepatitis C Genotypes in Australasia
Exhibit 10: Key Prevalence Data of Hepatitis C in Europe
Exhibit 11: Prevalence of Hepatitis C Genotypes in Eastern Europe
Exhibit 12: Prevalence of Hepatitis C Genotypes in Western Europe
Exhibit 13: Prevalence of Hepatitis C Genotypes in Central Europe
Exhibit 14: Key Prevalence Data of Hepatitis C in Latin America and Caribbean
Exhibit 15: Prevalence of Hepatitis C Genotypes in Tropical Latin America
Exhibit 16: Prevalence of Hepatitis C Genotypes in Andean Latin America
Exhibit 17: Prevalence of Hepatitis C Genotypes in Central Latin America
Exhibit 18: Prevalence of Hepatitis C Genotypes in South Latin America
Exhibit 19: Key Prevalence Data of Hepatitis C in Middle East and North Africa
Exhibit 20: Prevalence of Hepatitis C Genotypes in North Africa/Middle East
Exhibit 21: Key Prevalence Data of Hepatitis C in North America
Exhibit 22: Prevalence of Hepatitis C Genotypes in High Income Countries in North America
Exhibit 23: Key Prevalence Data of Hepatitis C in South Asia
Exhibit 24: Prevalence of Hepatitis C Genotypes in South Asia
Exhibit 25: Key Prevalence Data of Hepatitis C in Sub-Saharan Africa
Exhibit 26: Prevalence of Hepatitis C Genotypes in Central Sub-Saharan Africa
Exhibit 27: Prevalence of Hepatitis C Genotypes in East Sub-Saharan Africa
Exhibit 28: Prevalence of Hepatitis C Genotypes in South Sub-Saharan Africa
Exhibit 29: Prevalence of Hepatitis C Genotypes in West Sub-Saharan Africa
Exhibit 30: Screening Tests for Hepatitis C Infection
Exhibit 31: Global Hepatitis C Market 2013-2018 (US$ billion)
Exhibit 32: Global Hepatitis C Market Segmentation by MOA
Exhibit 33: Global Hepatitis C Market Segmentation by MOA 2013
Exhibit 34: Global Hepatitis C Market by Geographical Segmentation 2013
Exhibit 35: Geographical Segmentation of Pegasys Revenue 2013
Exhibit 36: Roche: Pipeline Candidates for Hepatitis C
Exhibit 37: Victrelis’ Revenue 2011-2013 (US$ million)
Exhibit 38: Merck: Pipeline Candidates for Hepatitis C
Exhibit 39: Johnson & Johnson : Incivo’s Revenue 2011-2013 (US$ million)
Exhibit 40: Olysio’s Revenue 2014 (US$ million)
Exhibit 41: Vertex Pharmaceuticals: Incivek’s Revenue 2011-2013 (US$ million)
Exhibit 42: Vertex: Pipeline Candidates for Hepatitis C
Exhibit 43: Gilead: Pipeline Candidates for Hepatitis C
Exhibit 44: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
Exhibit 45: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
Exhibit 46: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Pharmaceuticals Division)
Exhibit 47: F. Hoffmann-La Roche: Geographical Segmentation by Revenue 2013 (Diagnostics Division)
Exhibit 48: Gilead: Geographical Segmentation by Revenue 2013
Exhibit 49: Johnson & Johnson: Business Segmentation by Revenue 2013
Exhibit 50: Johnson & Johnson: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 51: Johnson & Johnson: Geographical Segmentation by Revenue 2013
Exhibit 52: Merck & Co. Inc.: Business Segmentation by Revenue 2013
Exhibit 53: Merck & Co. Inc.: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 54: Merck & Co. Inc.: Sales by Geography 2013
Exhibit 55: Vertex Pharmaceuticals: Business Segmentation by Revenue 2013
Exhibit 56: Vertex Pharmaceuticals: Business Segmentation by Revenue 2012 and 2013 (US$ million)
【レポート販売概要】
■ タイトル：世界のC型肝炎治療薬市場（2014-2018）■ 英文：Global Hepatitis C Market 2014-2018
■ 発行日：2014年9月3日
■ 調査会社：TechNavio
■ 商品コード：IRTNTR4050
■ 調査対象地域：グローバル
- 徐放性コーティング剤の世界市場予測（～2024年）Growth in demand for sustained release coating in the In Vitro application is driving the market. The sustained release coating market size is projected to grow from USD 478 million in 2019 to USD 660 million by 2024, at a CAGR of 6.6%, during the forecast period. The demand for sustained release coating has improved in recent years due to its increased consumption in the APAC region. In addition, …
- 硫酸アンモニウムの世界市場予測Ammonium sulphate 2014 World Market Outlook and Forecast is an absolutely essential resource for anyone looking for detailed information on the mentioned market. Using a wide range of primary and secondary sources, we combined, analyzed and presented all available data about ammonium sulphate market in the all-in-one report issued in a logical and easily accessible format. In addition to the analy …
- ウェアラブル技術の世界市場：リストウェア、アイウェア、フットウェア、ネックウェア、ボディウェアThe overall market for wearable technology is expected to reach USD 31.27 Billion by 2020, at a CAGR of 17.8% between 2015 and 2020. This market is primarily driven by consumer preference for sophisticated gadgets, increasing popularity of smartwatches and wrist bands in the consumer market, increasing growth prospects of next-generation displays and integrated consumer wearable devices, increasin …
- Royal Dutch Shell plc社の石油・ガス開発・生産動向及びコスト分析（2013年第4四半期）Royal Dutch Shell plc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2013 Summary Royal Dutch Shell plc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source …
- レシチンの世界市場分析：由来別（大豆、菜種、ひまわり）、用途別（即席食品、製パン、菓子、医薬品、動物飼料、工業用）、地域別、セグメント予測、2014-2025The global lecithin market is expected to reach USD 1.49 billion by 2025, according to a new report by Grand View Research, Inc. The growing awareness about natural emulsifiers and its rising demand in the manufacturing of food products is expected to drive the market growth.The emulsification and lubricant properties exhibited by lecithin coupled with eco-friendly nature have increased its import …
- シリコーンオイルの世界市場予測（～2020）The global silicone oil market was valued at USD 1.78 Billion in 2014 and is expected to reach USD 2.41 Billion by 2020, at a CAGR of 4.85% from 2015 to 2020. Increasing demand from end-use industries such as personal care and automotive, increasing demand from emerging economies such as China, India, Brazil, and favorable properties of silicone oil are some of the drivers for the growth of this m …
- 学生情報管理システム（SIMS）の世界市場2016-2020About the Student Information Management Systems Market The primary roles of the SIMS software entail collection, organization, and management of data. It can also generate critical reports and dashboards, which provide insights about queries and setbacks. In addition, the system provides a plethora of data sources, which enable educational institutions to take data-backed decisions. Therefore, ap …
- グローバル製薬産業サーベイ（2013-2014）：市場動向、マーケティング戦略Why was the report written? This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global pharmaceutical industry executives. The report provides data and analysis on global pharmaceutical industry suppliers’ media spend, marketing and sales strategies, and practices and business planning within the global pharmaceutical industry. This report includes …
- 臍帯血バンクサービスの世界市場2015-2022According to Stratistics MRC, the Cord Blood Banking Services market accounted for $12.50 billion in 2015 and is expected to grow at a CAGR of 6.41% to reach $19.32 billion by 2022. The factors such as increasing stem cell therapy applications in diseased treatments, growing number of advancements in technologies, rising awareness of cord blood banking services and growing incidence in prevalence …
- 鼻出血用デバイスの世界市場展望2017-2026According to Stratistics MRC, the Global Epistaxis Device market is accounted for $17,848.91 thousands in 2017 and is expected to reach $34,508.19 thousands by 2026 growing at a CAGR of 7.6% during the forecast period. Some of the key factors such as increasing incidences of the dry nasal membrane and abnormal nosebleeds are expected to boost demand for the market. Moreover, the side effects such …
- Google Update May 20101. Introduction.. 3 2. Google and ...
- 1,3-プロパンジオールの世界市場1,3-Propanediol is an organic compound manufactured through fermentation of biobased feedstock such as corn sugar, crude glycerol etc. Conventionally, The global 1,3-Propanediol market is estimated to reach $621.2 million by 2021 growing at a CAGR of 10.4% from 2014. This report on 1,3-Propanediol market covers all major regions such as Asia-Pacific (APAC), Americas, and Europe, Middle East & Afri …
- AaaS（アナリティクス・アズ・ア・サービス）の世界市場2016-2020About Global Analytics as a Service AaaS emerged from the integration of cloud computing and analytics solutions. It acts as a service model that involves analysis taking place using analytics software and being delivered through web-based technologies. AaaS providers offer services under subscription-based or pay-per-use models. AaaS products include cloud-based BI solutions and SaaS-based social …
- BRIC（ブラジル/ロシア/インド/中国）の腎盂形成処置動向（～2020）BRIC Pyeloplasty Procedures Outlook to 2020 Summary GlobalData’s new report, "BRIC Pyeloplasty Procedures Outlook to 2020", provides key market data on the BRIC Pyeloplasty Procedures. The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represent …
- Cytomegalovirus (CMV) Infections – Pipeline Assessment and Market Forecasts to 2019Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Cytomegalovirus (CMV) Infections - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Cytomegalovirus (CMV) Infections Therapeutics market. The report ident …
